Same-day Discharge Following Catheter Ablation and Venous Closure With VASCADE MVP: A Post-market Registry.

Zayd A Eldadah Amin Al-Ahmad Thomas Jared Bunch David B DeLurgioRahul N DoshiBruce G HookPatrick M HranitzkyCharles A JoynerSuneet MittalChristopher PorterfieldJavier E SanchezSenthil K ThambidoraiOussama M WazniH Thomas McElderry

Published in: Journal of cardiovascular electrophysiology (2022)

In this study, 99.7% of patients achieving SDD required no additional hospital intervention for access site-related complications during follow-up. SDD appears feasible and safe for eligible patients after catheter ablation for paroxysmal or persistent AF in which the VASCADE MVP is used for venous access-site closure. This article is protected by copyright. All rights reserved.

Keyphrases

catheter ablation
atrial fibrillation
left atrial
left atrial appendage
end stage renal disease
ejection fraction
randomized controlled trial
newly diagnosed
chronic kidney disease
heart failure
healthcare
peritoneal dialysis
emergency department
risk factors
mitral valve
electronic health record